The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study
Open accessAbstract
BACKGROUND: Severe sepsis is common and frequently fatal, and community-acquired pneumonia (CAP) is the leading cause. Although severe sepsis is often attributed to uncontrolled and unbalanced inflammation, evidence from humans with infection syndromes across the breadth of disease is lacking. In this study we describe the systemic cytokine response to pneumonia and determine if specific patterns, including the balance of proinflammatory and anti-inflammatory markers, are associated with severe sepsis and death. METHODS: This is a cohort study of 1886 subjects hospitalized with CAP through the emergency departments in 28 US academic and community hospitals. We defined severe sepsis as CAP complicated by new-onset organ dysfunction, following international consensus conference criteria. We measured plasma tumor necrosis factor, IL-6 (interleukin 6), and IL-10 levels daily for the first week and weekly thereafter. Our main outcome measures were severe sepsis and 90-day mortality. RESULTS: A total of 583 patients developed severe sepsis (31%), of whom 149 died (26%). Systemic cytokine level elevation occurred in 82% of all subjects with CAP. Mean cytokine concentrations were highest at presentation, declined rapidly over the first few days, but remained elevated throughout the first week, beyond resolution of clinical signs of infection. Cytokine levels were highest in fatal severe sepsis and lowest in CAP with no severe sepsis. Unbalanced (high/low) cytokine patterns were unusual (4.6%) and not associated with decreased survival. Highest risk of death was with combined high levels of the proinflammatory IL-6 and anti-inflammatory IL-10 cytokine activity (hazard ratio, 20.5; 95% confidence interval, 10.8-39.0) (P<.001). CONCLUSIONS: The circulating cytokine response to pneumonia is heterogeneous and continues for more than a week after presentation, with considerable overlap between those who do and do not develop severe sepsis. Unbalanced activation is uncommon, and mortality is highest when both proinflammatory and anti-inflammatory cytokine levels are high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Estimation of Relationships for Limited Dependent Variables
Tobin, J. (1958) · Econometrica · doi:10.2307/1907382 · Cited by 6,996
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360402 · Cited by 4,582
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., Bastos, P. G., Sirio, C. A., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · Chest · doi:10.1378/chest.100.6.1619 · Cited by 3,439
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. (1992) · Chest · doi:10.1378/chest.102.6.1919b · Cited by 2,880
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Conference, F. T. I. S. D., Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., et al. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1662-x · Cited by 2,871
Sepsis in European intensive care units: Results of the SOAP study*
Vincent, J.-L., Sakr, Y., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., Moreno, R., Carlet, J., Le Gall, J.-R., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194725.48928.3a · Cited by 2,836
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
A SAS Procedure Based on Mixture Models for Estimating Developmental Trajectories
JONES, B. L., NAGIN, D. S., & ROEDER, K. (2001) · Sociological Methods & Research · doi:10.1177/0049124101029003005 · Cited by 2,370
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Detection of circulating tumor necrosis factor after endotoxin administration
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., & Wilmore, D. W. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182301 · Cited by 1,677 · cited 2×
“001 I and II 578 (31) 90 (15) 488 (37) 5 (3) 82 (19) III 475 (25) 104 (18) 371 (28) 17 (11) 84 (20) IV 629 (33) 260 (45) 369 (28) 72 (48) 184 (43) V 204 (11) 129 (22) 75 (6) 55 (37) 74 (17) APACHE III 56.”
Analyzing developmental trajectories of distinct but related behaviors: A group-based method.
Nagin, D. S., & Tremblay, R. E. (2001) · Psychological Methods · doi:10.1037//1082-989x.6.1.18 · Cited by 1,280
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Serum Cytokine Levels in Human Septic Shock
Pinsky, M. R., Vincent, J.-L., Deviere, J., Alegre, M., Kahn, R. J., & Dupont, E. (1993) · Chest · doi:10.1378/chest.103.2.565 · Cited by 884
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., Della Porta, R., Giorgio, C., Blasi, F., Umberger, R., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-808oc · Cited by 857
The Effects of Ibuprofen on the Physiology and Survival of Patients with Sepsis
Bernard, G. R., Wheeler, A. P., Russell, J. A., Schein, R., Summer, W. R., Steinberg, K. P., Fulkerson, W. J., Wright, P. E., Christman, B. W., Dupont, W. D., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361303 · Cited by 837
Bone, R. C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-8-199610150-00009 · Cited by 718 · cited 1×
“001 I and II 578 (31) 90 (15) 488 (37) 5 (3) 82 (19) III 475 (25) 104 (18) 371 (28) 17 (11) 84 (20) IV 629 (33) 260 (45) 369 (28) 72 (48) 184 (43) V 204 (11) 129 (22) 75 (6) 55 (37) 74 (17) APACHE III 56.”
Surviving Intensive Care: a report from the 2002 Brussels Roundtable
Angus, D. C., Carlet, J., & Participants, O. B. O. T. 2. B. R. (2003) · Intensive Care Medicine · doi:10.1007/s00134-002-1624-8 · Cited by 530
Halm, E. A., Fine, M. J., Marrie, T. J., Coley, C. M., Kapoor, W. N., Obrosky, D. S., & Singer, D. E. (1998) · JAMA · doi:10.1001/jama.279.18.1452 · Cited by 518
Panacek, E. A., Marshall, J. C., Albertson, T. E., Johnson, D. H., Johnson, S., MacArthur, R. D., Miller, M., Barchuk, W. T., Fischkoff, S., Kaul, M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145229.59014.6c · Cited by 387
Annane, D., Sebille, V., & Charpentier, C. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00997-2 · Cited by 382
Kinasewitz, G. T., Yan, S. B., Basson, B., Comp, P., Russell, J. A., Cariou, A., Um, S. L., Utterback, B., Laterre, P.-F., Dhainaut, J.-F., et al. (2004) · Critical Care · doi:10.1186/cc2459 · Cited by 363
Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned
Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 288
Dhainaut, J.-F. A., Tenaillon, A., Le Tulzo, Y., Schlemmer, B., Solet, J.-P., Wolff, M., Holzapfel, L., Zeni, F., Dreyfuss, D., Mira, J.-P., et al. (1994) · Critical Care Medicine · doi:10.1097/00003246-199411000-00005 · Cited by 269
Taniguchi, T., Koido, Y., Aiboshi, J., Yamashita, T., Suzaki, S., & Kurokawa, A. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00005 · Cited by 245
L-arginine pathway in the sepsis syndrome
LORENTE, J. A., LANDÍN, L., DE PABLO, R., RENES, E., & LISTE, D. (1993) · Critical Care Medicine · doi:10.1097/00003246-199309000-00010 · Cited by 236
Bone, R. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540070061032 · Cited by 224
Lekkou, A., Karakantza, M., Mouzaki, A., Kalfarentzos, F., & Gogos, C. A. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.1.161-167.2004 · Cited by 202
Fein, A. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540300050033 · Cited by 173
Spies, C. D., Reinhart, K., Witt, I., Meier-Hellmann, A., Hannemann, L., Bredle, D. L., & Schaffartzik, W. (1994) · Critical Care Medicine · doi:10.1097/00003246-199411000-00007 · Cited by 170
New strategies for clinical trials in patients with sepsis and septic shock
Cohen, J., Guyatt, G., Bernard, G. R., Calandra, T., Cook, D., Elbourne, D., Marshall, J., Nunn, A., & Opal, S. (2001) · Critical Care Medicine · doi:10.1097/00003246-200104000-00039 · Cited by 158
YU, M., & TOMASA, G. (1993) · Critical Care Medicine · doi:10.1097/00003246-199311000-00010 · Cited by 158
Dhainaut, J.-F., Tenaillon, A., Hemmer, M., Damas, P., Tulzo, Y. L., Radermacher, P., Schaller, M., Sollet, J.-P., Wolff, M., Holzapfel, L., et al. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00021 · Cited by 153
Effect of Pentoxifylline in Severe Sepsis
Staubach, K.-H., Schröder, J., Stuber, F. E., Gehrke, K., Traumann, E., & Zabel, P. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.1.94 · Cited by 144
Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study
Avontuur, J. A. M., Nolthenius, R. P. T., van Bodegom, J. W., & Bruining, H. A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00012 · Cited by 120
Zéni, F., Pain, P., Vindimian, M., Gay, J.-P., Géry, P., Bertrand, M., Page, Y., Page, D., Vermesch, R., & Bertrand, J.-C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199602000-00005 · Cited by 87
Schilling, J., Cakmakci, M., Bättig, U., & Geroulanos, S. (1993) · Intensive Care Medicine · doi:10.1007/bf01694775 · Cited by 67
Alterations of Lipid Metabolism in Mice Injected with Endotoxin
Sakaguchi, O., & Sakaguchi, S. (1979) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1979.tb00443.x · Cited by 58
A Tobit Variance-Component Method for Linkage Analysis of Censored Trait Data
Epstein, M. P., Lin, X., & Boehnke, M. (2003) · The American Journal of Human Genetics · doi:10.1086/367924 · Cited by 49
Steigbigel, N. H. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0014-x · Cited by 42
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · Survey of Anesthesiology · doi:10.1097/00132586-199910000-00015 · Cited by 37
Sepsis and controlled clinical trials
Bone, R. C. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00001 · Cited by 31
Cited by
Seymour, C. W., Liu, V. X., Iwashyna, T. J., Brunkhorst, F. M., Rea, T. D., Scherag, A., Rubenfeld, G., Kahn, J. M., Shankar-Hari, M., Singer, M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0288 · Cited by 3,939
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
Seymour, C. W., Kennedy, J. N., Wang, S., Chang, C.-C. H., Elliott, C. F., Xu, Z., Berry, S., Clermont, G., Cooper, G., Gomez, H., et al. (2019) · JAMA · doi:10.1001/jama.2019.5791 · Cited by 1,567
Self-citationZarbock, A., Kellum, J. A., Schmidt, C., Van Aken, H., Wempe, C., Pavenstädt, H., Boanta, A., Gerß, J., & Meersch, M. (2016) · JAMA · doi:10.1001/jama.2016.5828 · Cited by 1,143
Self-citationMarik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Faix, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.764490 · Cited by 663
Metadata
- Authors
- Kellum, J. A.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2007-08-13
- Volume
- 167
- Issue
- 15
- Pages
- 1655
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2105981152
- Cited by
- 828
- References
- 54
- FWCI
- 21.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.